Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MSI-H/dMMR + PD-L1 expression
i
Other names:
PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule
Associations
(4)
News
Trials
C3 | Sensitive
C4 | Sensitive
C3 | Resistant
C4 | Resistant
Show legend
Drug categories
Immunotherapy
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Chemotherapy
Cancel
Neuroendocrine Tumor
Cholangiocarcinoma
Triple Negative Breast Cancer
pembrolizumab
C4
MSI-H/dMMR + PD-L1 expression
|
Cholangiocarcinoma
|
pembrolizumab
Immunotherapy
C3
MSI-H/dMMR + PD-L1 expression
|
Neuroendocrine Tumor
|
Immunotherapy
atezolizumab
C4
MSI-H/dMMR + PD-L1 expression
|
Triple Negative Breast Cancer
|
atezolizumab
sacituzumab govitecan-hziy
C4
MSI-H/dMMR + PD-L1 expression
|
Triple Negative Breast Cancer
|
sacituzumab govitecan-hziy
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login